Biotech news
Americas
The governor of Massachusetts has revealed a legislative proposal aimed at providing up to $500 million over the next five years in the life sciences sector. 26 June 2017
Americas
Earlier this month, the US Supreme Court handed down its decision in the biosimilars battle between Amgen and Sandoz, centring on the Biologics Price Competition and Innovation Act. 23 June 2017
Americas
“There’s one stick with this carrot—the whistleblower protection law,” explained Anne Elise Li, IP counsel at Crowell & Moring, in reference to the Defend Trade Secrets Act. 22 June 2017
Americas
The biotechnology industry is at a crossroads over 35 USC section 101, which covers patent sub-ject matter eligibility. 22 June 2017
Pharma
Panellists discussed the potential impact of the UK’s decision to leave the EU on patents yesterday at the 2017 BIO International Convention. 22 June 2017
Americas
Academic patents and their subsequent licensing contributed up to $1.3 trillion to US industry gross output between 1996 and 2015, the Biotechnology Innovation Organization has found. 22 June 2017
Biotech
Google’s parent company Alphabet has invested $300 million in a new fund that will buy stakes in European biotech companies. 21 June 2017
Americas
“I will think about this every day until the day I die … whether there was something more we could have done to have won the [Brexit] referendum,” said former UK Prime Minister David Cameron. 21 June 2017
Africa
The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention. 20 June 2017
Americas
The biopharma industry must do its part in changing the public's view of the sector, because the political reality is that it is unpopular, according to Brent Saunders, chairman, president and CEO of Allergan. 20 June 2017